Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | ![]() Global Heparin Market Gears Up for a 5% Growth Journey to 2026Heparin market is driven by factors like chronic diseases, geriatric population, anticoagulant demand, heparin use in surgeries, and availability of synthetic and semi-synthetic heparin mimetics.
Heparin is being more widely used in a variety of applications. What is driving the growth of the heparin market? Anticoagulants act by reducing the ability of the blood to clot. It aids in the prevention of clot formation as well as the prevention of additional clot enlargement. As a result, it can be employed in a variety of applications. The use of low molecular weight unfractionated heparin instead of heparin to prevent deep vein thrombosis or pulmonary embolism is increasing. Increases Demand Low-molecular- North America has the largest market share, but APAC is expected to grow the fastest in the heparin market. The heparin market is dominated by North America, followed by Europe and Asia Pacific. This is mostly due to the region's high chronic disease burden, the presence of advanced and robust healthcare infrastructure, rising need for heparin in various procedures, and rising occurrences of cardiovascular ailments. However, Asia-Pacific is expected to grow significantly during the forecast period due to the region's position as the largest supplier base of crude heparin, the rising incidence of venous thromboembolism and cardiovascular diseases, an increase in surgical procedures, and an increase in the geriatric population. Competitive Landscape Analysis: Heparin Market The global heparin market is marked by the presence of established market players such as Baxter International Inc., B. Braun Holding GmbH & Co. KG, Dr. Reddy's Laboratories Ltd., and Fresenius SE & Co KGaA among others. Get Detailed Insights on Heparin Market with TOC and a Sample Report PDF @ https://meditechinsights.com/ End
|
|